Search Results for "Xerion Pharmaceuticals Inc"
Original Source: Xerion Pharmaceuticals GmbH
Xerion's proprietary protein/ligand identification technology platform, Xcelerate, focuses on the combination of proteome-wide protein separation from any biological source, high-throughput protein identification by mass spectrometry, and simultaneous generation of ligands specific for all the separated proteins. This can replace the lengthy process of gene isolation, subcloning, expression, and recombinant protein purification. Obtaining specific ligands for any one protein is tedious and time-consuming by...
Matching PubMed Articles